Search research articles
Contact Us
Filters
Showing results (111-120 of 134) with videos related to
Page
of 14
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 26, 2021
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response
E Nettis, S M Ferrucci, G Pellacani, et al.
British Journal of Cancer
|
February 24, 2006
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study
R Zanetti, S Rosso, C Martinez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 3, 2020
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore
A V Marzano, A Chiricozzi, G Giovanardi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement
Z Apalla, V Nikolaou, D Fattore, et al.
European Review for Medical and Pharmacological Sciences
|
January 2, 2023
Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population
G Damiani, R Finelli, K Kridin, et al.
Photodermatology, Photoimmunology & Photomedicine
|
October 6, 2000
p53, cyclin-D1, PCNA, AgNOR expression in squamous cell cancer of the lip: a multicenter study
G Fabbrocini, N Russo, M C Pagliuca, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 17, 2021
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting
S Ribero, A Ramondetta, G Fabbrocini, et al.
The British Journal of Dermatology
|
April 28, 2015
Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry
V Bettoli, L Naldi, S Cazzaniga, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 4, 2018
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group
M Napolitano, P G Calzavara-Pinton, A Zanca, et al.
Clinical and Experimental Dermatology
|
December 30, 2018
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort
L Bianchi, R D Caposiena Caro, G Ganzetti, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 134) with videos related to
Sort By:
Page
of 14
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 26, 2021
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response
E Nettis, S M Ferrucci, G Pellacani, et al.
British Journal of Cancer
|
February 24, 2006
Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study
R Zanetti, S Rosso, C Martinez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 3, 2020
Creation of a severity index for hidradenitis suppurativa that includes a validated quality-of-life measure: the HIDRAscore
A V Marzano, A Chiricozzi, G Giovanardi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
December 15, 2021
European recommendations for management of immune checkpoint inhibitors-derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement
Z Apalla, V Nikolaou, D Fattore, et al.
European Review for Medical and Pharmacological Sciences
|
January 2, 2023
Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population
G Damiani, R Finelli, K Kridin, et al.
Photodermatology, Photoimmunology & Photomedicine
|
October 6, 2000
p53, cyclin-D1, PCNA, AgNOR expression in squamous cell cancer of the lip: a multicenter study
G Fabbrocini, N Russo, M C Pagliuca, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 17, 2021
Effectiveness of Secukinumab in the treatment of moderate-severe hidradenitis suppurativa: results from an Italian multicentric retrospective study in a real-life setting
S Ribero, A Ramondetta, G Fabbrocini, et al.
The British Journal of Dermatology
|
April 28, 2015
Overweight, diabetes and disease duration influence clinical severity in hidradenitis suppurativa-acne inversa: evidence from the national Italian registry
V Bettoli, L Naldi, S Cazzaniga, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 4, 2018
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group
M Napolitano, P G Calzavara-Pinton, A Zanca, et al.
Clinical and Experimental Dermatology
|
December 30, 2018
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort
L Bianchi, R D Caposiena Caro, G Ganzetti, et al.
Page
of 14